Navigation Links
Ovid Supports Chinese Medical Research Market with the Release of OvidChinese, a Local-Language Portal Solution to Search Chinese-Language Medical Resources
Date:9/1/2011

NEW YORK, Sept. 1, 2011 /PRNewswire/ -- Ovid, part of Wolters Kluwer Health and a global leader in the development and delivery of customizable research information solutions for the medical, scientific and academic markets, is pleased to announce the release of Ovid's latest local language search portal, OvidChinese. OvidChinese allows healthcare practitioners, clinicians, students, and researchers to search, browse, and manage results of core Chinese-language medical content.

"We are excited to introduce OvidChinese at the Beijing Book Fair," said Karen Abramson, President & CEO of Wolters Kluwer Health Medical Research. "OvidChinese fills an important gap in this high-growth market for Chinese medical publishers who want to broaden the reach of their content through our global network and for researchers, students and healthcare practitioners who want a reliable, efficient way to search important Chinese medical literature to improve patient care, support medical studies, and inform ongoing research."

OvidChinese is accessible anytime, anywhere a user has internet access.  Users can search and browse content by subject area, and perform other research tasks including:

  • Enter search terms in Simplified Chinese
  • Refine book searches by specific criteria
  • Search multiple resources simultaneously
  • Access premium resources published by the top publishers in China
  • Navigate between table of contents, chapters, and sections
  • Email or export images from the image gallery to PowerPoint
  • Capture key content by exporting citations to PDF
  • Offer Chinese-language information to students, faculty, and clinicians

From August 31 through September 04, Ovid will offer demonstrations of OvidChinese at the Beijing International Book Fair in China, Stand E2.C30.

Ovid continues to expand its content offerings on OvidChinese with new and established partnerships among leading Chinese medical publishers, including Higher Education Press (HEP), People's Medical Publishing House (PMPH), People's Military Medical Digital Press (PMMDP), and Shanghai Scientific & Technical Publishers (SSTP).

More than 400 titles are currently available on the portal with several hundred more titles planned for later this year. The content covers Traditional Chinese medicine, acupuncture, and therapeutic areas such as surgery and regenerative medicine, among other disciplines. Learn about all the current title offerings at www.ovid.com/ovidchinese. Some of the core medical titles available on OvidChinese include:

  • Massotherapy as the Best Medicine, PMMDP
  • Diagnosis, Treatment and Care of Respiratory Diseases by TCM, PMMDP
  • Case Records of Clinical Practice in Internal Medicine, PMMDP
  • Research on the Functional Genomics of the Rat Regenerating Liver, HEP
  • Regenerative Medicine: From Basic to Clinical Research, SSTP

Ovid is already well-established within the research community known around the world for OvidSP, the industry-leading online research platform with unique tools and features designed to maximize search precision and efficiency, and simplify and speed analysis and workflow—all in a simple, integrated and easy-to-use system. Ovid introduced its first local-language portal in 2010 with OvidFrancais and has portals planned for Arabic, Spanish, among other languages.  

About Ovid and Wolters Kluwer Health

Ovid® is a global information solutions provider offering clinicians, professionals, students, and researchers in the medical, scientific, and academic fields customizable solutions of content, tools, and services that make research smarter, faster, and more effective. Ovid is used by the world's leading colleges and universities; medical schools; academic research libraries and library consortia; hospitals and healthcare systems; pharmaceutical, engineering and biotechnology companies; and HMOs and clinical practices.

Ovid is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2010 annual revenues of euro 3.6 billion ($4.7 billion).


'/>"/>
SOURCE Wolters Kluwer Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
2. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
4. Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
5. New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
6. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
7. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
8. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
9. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
10. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
11. New Clinical Data Further Supports Chromium Picolinates Role in Enhancing Brain Activity in Older Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), ... company,s second affiliate in Latin America . ... ... Colombia ... ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
Breaking Medicine News(10 mins):